Literature DB >> 17978307

Remission of proteinuria improves prognosis in IgA nephropathy.

Heather N Reich1, Stéphan Troyanov, James W Scholey, Daniel C Cattran.   

Abstract

Proteinuria has been shown to be an adverse prognostic factor in IgA nephropathy. The benefit of achieving a partial remission of proteinuria, however, has not been well described. We studied 542 patients with biopsy-proven primary IgA nephropathy in the Toronto Glomerulonephritis Registry and found that glomerular filtration rate (GFR) declined at -0.38 +/- 0.61 ml/min per 1.73 m2/mo overall, with 30% of subjects reaching end-stage renal disease. Multivariate analysis revealed that proteinuria during follow-up was the most important predictor of the rate of GFR decline. Among the 171 patients with <1 g/d of sustained proteinuria, the rate of decline was 90% slower than the mean rate. The rate of decline increased with the amount of proteinuria, such that those with sustained proteinuria >3 g/d (n = 121) lost renal function 25-fold faster than those with <1 g/d. Patients who presented with > or =3 g/d who achieved a partial remission (<1 g/d) had a similar course to patients who had < or =1 g/d throughout, and fared far better than patients who never achieved remission. These results underscore the relationship between proteinuria and prognosis in IgA nephropathy and establish the importance of remission.

Entities:  

Mesh:

Year:  2007        PMID: 17978307     DOI: 10.1681/ASN.2007050526

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  187 in total

Review 1.  Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?

Authors:  Michael R Lattanzio; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

2.  Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy.

Authors:  Yusuke Okabayashi; Nobuo Tsuboi; Kotaro Haruhara; Go Kanzaki; Kentaro Koike; Akihiro Shimizu; Yoichi Miyazaki; Iwao Ohno; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Clin Exp Nephrol       Date:  2016-02-01       Impact factor: 2.801

Review 3.  Corticosteroid therapy in IgA nephropathy.

Authors:  Jicheng Lv; Damin Xu; Vlado Perkovic; Xinxin Ma; David W Johnson; Mark Woodward; Adeera Levin; Hong Zhang; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

4.  Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.

Authors:  Miho Tatematsu; Yoshinari Yasuda; Yoshiki Morita; Izumi Sakamoto; Kei Kurata; Tomohiko Naruse; Rhohei Yamamoto; Naotake Tsuboi; Waichi Sato; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2012-05-23       Impact factor: 2.801

Review 5.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

6.  The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases.

Authors:  Marie C Hogan; Heather N Reich; Peter J Nelson; Sharon G Adler; Daniel C Cattran; Gerald B Appel; Debbie S Gipson; Matthias Kretzler; Jonathan P Troost; John C Lieske
Journal:  Kidney Int       Date:  2016-08-12       Impact factor: 10.612

7.  Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.

Authors:  Xin Han; Yi Xiao; Yi Tang; Xiaonan Zheng; Mawluda Anwar; Wei Qin
Journal:  Clin Exp Med       Date:  2019-09-21       Impact factor: 3.984

8.  High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

Authors:  Fengxiao Bu; Nicolo Ghiringhelli Borsa; Michael B Jones; Erika Takanami; Carla Nishimura; Jill J Hauer; Hela Azaiez; Elizabeth A Black-Ziegelbein; Nicole C Meyer; Diana L Kolbe; Yingyue Li; Kathy Frees; Michael J Schnieders; Christie Thomas; Carla Nester; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2015-08-17       Impact factor: 10.121

9.  Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis.

Authors:  Sean J Barbour; Daniel C Cattran; Gabriela Espino-Hernandez; Michelle A Hladunewich; Heather N Reich
Journal:  Kidney Int       Date:  2015-08-19       Impact factor: 10.612

10.  Clinicopathological characteristics of patients with immunoglobulin A nephropathy showing acute exacerbations after favorable long-term clinical courses.

Authors:  Mai Tanaka; Yoichi Miyazaki; Kentaro Koike; Hiroyuki Ueda; Nobuo Tsuboi; Keita Hirano; Hideo Okonogi; Makoto Ogura; Tetsuya Kawamura; Takashi Yokoo
Journal:  Clin Exp Nephrol       Date:  2015-08-20       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.